← Human Trials & Peer-Reviewed Studies
Maternal zinc supplementation improves hepatitis B antibody responses in infants but decreases plasma zinc level.
Plain-language guide to PMID 26208687 (2016): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 26208687
- Journal
- European journal of nutrition
- Year
- 2016
- Study type
- Randomized Controlled Trial
- Authors
- Ahmad SM et al. (8 authors)
- DOI
- 10.1007/s00394-015-0999-6
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The World Health Report identifies zinc deficiency as one of the major causes of disease in developing countries, and infants are at particular risk.
The researchers aimed to investigate the effect of maternal zinc supplementation on the infant's immune function in a population at risk of deficiency.
Who Took Part
PubMed indexes the participants as infants and young adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
Indicators of the infants' immune function measured included interleukin (IL)-7, thymic size and response to hepatitis B vaccination.
What Was Measured
The subject headings attached to it are Copper, Dietary Supplements, Hepatitis B, Hepatitis B Antibodies, Hepatitis B Surface Antigens, Hepatitis B Vaccines and Immunity, Innate.
The authors tagged it with the keywords HBV, IL-7, Infant and Zinc.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2016 (European journal of nutrition), a journal based in Germany.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.